SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-24-022703
Filing Date
2024-04-29
Accepted
2024-04-29 08:01:30
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20023222x2_defa14a.htm DEFA14A 6557
2 ny20023222x2_nc01.jpg GRAPHIC 360639
3 ny20023222x2_nc02.jpg GRAPHIC 215047
  Complete submission text file 0001140361-24-022703.txt   800880
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39696 | Film No.: 24886665
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)